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Abstract
Background: Inadequate pain assessment is a significant problem and a key barrier to
appropriate pain management. While pain assessment has become a standard, the practice
of assessing pain as the “fifth vital sign” has resulted in perfunctory recordings that are
less meaningful than intended. Unidimensional pain rating scales such as the numeric
rating scale (NRS) are quick to administer and provide an assessment of pain severity but
lack depth and are more useful for evaluating acute pain rather than chronic pain
(Younger, 2005; Goldsmith, 2018). A multidimensional pain assessment tool, which
assesses pain intensity as well as impact on functional status and quality of life would
have greater relevance in use for chronic pain management.
Purpose/Specific Aims: This project evaluates the feasibility, effectiveness, and impact
of using a multidimensional pain assessment tool in place of the currently used
unidimensional NRS to assess chronic pain in a primary care setting. A multidimensional
pain assessment tool that evaluates not only the severity of pain, but also the impact of
pain on quality and functioning could improve patient care and pain management.
Methods: Twenty-five patients with a diagnosis of chronic pain were evaluated during a
routine appointment at their primary care practice. Each participant was screened with the
Numeric Rating Scale (NRS) per usual practice at this setting. The nurse practitioner
(NP) then used the Pain, Enjoyment of life, and General Activity (PEG) scale to assess
each participant. A retrospective review of the electronic health record (EHR) identified
the NRS scores and the pain management modalities from two visits prior to the use of
the PEG assessment. A comparative analysis was done to look at similarities and

differences between the two pain scales, as well as to compare the pain management
modalities resultant from both measures.
Results: There was a visible, but not significant, increase in PEG scores with higher NRS
scores with a correlation coefficient of 0.22892610, t = 1.12784221 which was not
significant. There was some correlation between the NRS and the “P” of the PEG score,
which assesses pain intensity, although it also was not significant. The PEG scale had
greater variability in scores compared to the NRS, which is not unexpected as it is a
multidimensional rather than a unidimensional scale. Use of the PEG scale was
associated with an increase in multi-modal non-pharmacologic pain management
recommendations in this patient population that at baseline had largely been treated with
pharmacologic measures.
Conclusion: The use of the PEG tool provided a more comprehensive assessment than
did the NRS unidimensional pain scale, which focuses on pain intensity alone. Chronic
pain assessment that includes an evaluation of functional impact and quality of life
provides a richer picture of the individual’s status. In comparison to the NRS, the use of
the PEG assessment resulted in broader, more individualized pain management
recommendations that focused more on non-pharmacologic modalities.

Key Words: chronic pain; pain assessment tools; pain management; PEG scale,
multidimensional pain scale, functional pain assessment
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IMPLEMENTATION AND EVALUATION OF THE PEG PAIN ASSESSMENT
SCALE IN A PRIMARY CARE SETTING
Background and Significance
According to a 2016 survey by the National Health Interview Survey conducted by the
U.S. Department of Health and Human Services, approximately 50 million Americans
have significant chronic pain (Dahlhamer et al., 2018). Although there is no agreed upon
definition of chronic pain, it is commonly referred to as an unpleasant sense of
discomfort that is without biological value, lasting longer than the typical healing time,
not responsive to specific treatments or remedies, and of a duration greater than 3 months
(Katz, Rosenbloom, & Fashler, 2015). Unlike acute pain, which is considered a normal
response to a specific condition, is self-limiting and is usually treatable, chronic pain
serves no adaptive purpose and is less easily defined. The International Association Study
of Pain provides a taxonomy system that defines and classifies chronic pain into more
than 30 categories (Teede et al., 2019). This attests to the complexity of chronic pain, as
well as the inherent difficulties in pain assessment.
Of the 50 million Americans having chronic pain, 20 million or 8% of the U.S.
adult population have high impact pain. This is defined as pain that frequently and
significantly interferes with life or work activities (Dahlmaher et al., 2018). Chronic pain
is associated with increased mortality, independent of socio-demographic factors
(Torrance et al., 2011). Over the past two decades, the impact of pain and the
inadequacies of the health care system in alleviating pain have been in the forefront. In a
landmark 2001 report, The Joint Commission (TJC), formerly known as the Joint
Commission on Accreditation of Healthcare Organizations (JCAHO), which accredits
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and certifies nearly 21,000 health care organizations in the United States, called for
national standards in pain assessment and management. These standards included the
requirement that health care facilities “recognize the right of patients to appropriate
assessment and management of pain; to record the assessment in a way that facilitates
regular reassessment and follow-up…” (Phillips, 2010, Standard PC. 6.10), While these
standards call for the assessment and management of patients’ pain, they do not require a
specific assessment tool or specific timing for reassessment (Joint Commission
Perspectives, 2014). The Center for Disease Control (CDC) and TJC both note that while
unidimensional numeric pain scales can be appropriate and helpful as part of an initial
assessment, they are usually inadequate on their own. Current guidelines advocate for the
use of a functional assessment to improve the efficacy and safety of chronic pain
management (CDC, 2016; Moore, Anderson, & Dorflinger, 2016).
Problem Statement and Study Question
Given the prevalence and significance of high impact chronic pain, the impetus is on
health care providers to utilize effective assessment tools in order to effectively guide the
implementation of patient-centered pain management. How would the use of a
multidimensional pain assessment tool compare to a unidimensional assessment tool in
evaluating and managing chronic pain in a primary care setting?
Literature Review
More than 50% of Americans who report chronic pain receive pain-related care in the
primary care setting (Anderson, Wang, & Zlateva, 2012). Despite many years of multiple
national initiatives, improvements in chronic pain management have been limited
(Reuben et al., 2015). An estimated 40-60% of those affected by chronic pain report

3

inadequate pain management (Busse et al.,2017). Effective pain management is
dependent upon an appropriate and comprehensive pain assessment.
Pain assessment ratings or scores, based upon established pain scales or
instruments, are the basis of pain management. Pain is subjective, therefore self-report is
widely accepted to be “the golden rule.” In 1968, Mary Margo McCaffery, a nursing
pioneer in the research, education, and care of people with pain, stated “Pain is whatever
the experiencing person says it is, existing whenever he says it does” (McCaffrey, 1968).
This definition of pain continues to be accepted and used in both medicine and nursing
today. Therefore, a report from the patient is the single most reliable indicator of pain.
The most frequently used and well-studied unidimensional pain scales include
the visual analog scale (VAS) and the numeric rating scale (NRS). Both of these scales
consist of scores from 0 to 10 which are listed from left to right, with 0 (no pain) being on
the far left and 10 (the worst pain imaginable) being on the far right. An alternative to the
VAS and NRS scales is the FACES rating scale. The FACES scale is a useful option for
young children or those who cannot speak English fluently (Jensen, 2003; Younger,
2009). These scales are simple, reliable, and valid, but have largely been developed and
utilized in the acute care setting and therefore have limited application to chronic pain
assessment.
Several studies have found that unidimensional pain scales, such as the NRS, are
inconsistently used and provide minimal guidance in clinical care (Buckenmaier et al.,
2013). Chronic pain is a complex, individualized experience, which calls for the use of a
multidimensional pain assessment tool (Anderson, Wang, & Zlateva, 2012). These
instruments typically measure several dimensions of pain, including pain intensity,
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quality, interference with functioning, and effects on general quality of life. The McGill
Pain Questionnaire is a 20-item, well-validated tool, which has pain ratings using sensory
terms, such as sharp or stabbing, and affective terms, such as sickening. The Brief Pain
Inventory (BPI) is a comprehensive multi-dimensional pain assessment that assesses two
broad pain domains: 1) the sensory intensity of pain, and 2) the degree to which pain
interferes with different areas of life. The Brief Pain Inventory (BPI) and the McGill Pain
Questionnaire have a “short-form” which are 17 and 15 questions respectively, taking an
estimated fifteen minutes to complete (Younger, 2009).
The Pain, Enjoyment of life, and General Activity (PEG) assessment tool (Figure
1) is a three-item scale based upon the BPI. This is a brief, yet multidimensional pain
measure, which assess pain intensity (P), interference with enjoyment of life (E), and
interference with general activity (G). Each item is rated zero to ten and is based on
“average in the past week.” In a longitudinal study of 500 primary care patients with
chronic pain and a cross-sectional study of 646 ambulatory care veterans, the PEG was
found to have reliability, construct validity (r=0.77-0.95), and responsiveness compared
to the BPI (Krebs et al., 2009). The PEG has also been found to be more responsive than
the 36-Item Short Form Health Survey (SF-36), a detailed bodily pain scale, when used
in outcome assessment to evaluate improvements in pain (Krebs et al., 2010).

Figure 1. PEG: A Three-Item Scale Assessing Pain Intensity and Interference
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Figure 1 From Krebs et al., 2009.

A small but relevant quality improvement study using the PEG in a primary care
practice found that use of the PEG was well-accepted. The findings included: 94%
provider adherence with documentation in the medical record. Fifty-six percent of
providers reported increased conversations with patients about chronic pain and 38%
reported an improved understanding of the patient’s pain and functional status with use of
the PEG (Stevens, 2019).
The Center for Disease Control (CDC) 2018 guidelines for the management of
chronic pain addresses patient-centered clinical practices, which includes conducting
thorough assessments, considering all possible treatments, and evaluating outcomes.. The
CDC specifically recommends use of the PEG in chronic pain management, particularly
when considering opioid treatment, as well as to track outcomes (Dowell, Haegerich, &
Chou, 2016). According to the 2015 National Pain Strategy that was based upon a joint
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effort of the National Institutes of Health (NIH) and the Institute of Medicine (IOM),
goals of treatments should include improvement in both pain relief and function, which is
tied to quality of life (Lu, 2015). This report recommends the use of multimodal pain
management strategies, including both non-pharmacologic and pharmacologic measures
as a means to better manage pain and improve function (Lu, 2015). The National Pain
Strategy included a classification of pharmacologic and non-pharmacologic pain
management modalities, also referred to as health care services for pain. These consist of
the following categories: medications, professional services, procedures, and
miscellaneous non-pharmacologic measures (Interagency Pain Research Coordinating
Committee, 2016) (See Appendix C). A multidimensional pain assessment tool, such as
the PEG scale, which includes functional status and quality of life measures would give
the health care provider a more effective guide for pain management beyond pain
intensity measures alone.
Organizational Assessment/Local Problem
Over the past two decades, the burden of chronic pain and the opioid epidemic have both
raised significant concerns on the societal, political, and health care fronts, at both the
local and national level. Despite standards and recommendations that call for pain
assessment, the actual practice and application of pain assessment is highly variable. A
survey of members of the American Pain Society found that while pain ratings were
obtained during “All visits” by 43.2% and “Most of the time” by 21.1%, many of the
members reported that the pain ratings had “Minimal” impact on the care of their patients
(Bačkonja & Farrar, 2015). In a primary care practice study, 80% of the providers
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reported that functional assessments have value in treating patients with chronic pain, but
only 20% reported using them regularly (Stevens, 2019).
The 2010 Patient Protection and Affordable Care Act required the Department of
Health and Human Services (HHS) to enlist the Institute of Medicine (IOM) in order that
pain be examined as a public health problem. In 2016, HHS released the National Pain
Strategy, the federal government’s first coordinated, evidence-based plan, to reduce the
burden of chronic pain affecting millions of Americans. According to B. DeSalvo, M.D.,
M.P.H., M.Sc., HHS Acting Assistant Secretary for Health, “This report identifies the
key steps we can take to improve how we prevent, assess and treat pain in this country”
(Interagency Pain Research Coordinating Committee, 2016). According to the National
Pain Strategy, assessment of chronic pain and goals of treatments must be identified,
specifically to include improvement in both pain relief and function ((National Institutes
of Health, 2019). This report specifically recommends the use of multimodal pain
management strategies, including both non-pharmacologic and pharmacologic measures
as a means to better manage pain and improve function, which is tied to quality of life
(National Institutes of Health, 2019).
In 2016, the Center of Disease Control released the “Guidelines for Prescribing
Opioids for Chronic Pain” which included the recommendations: to establish and
measure goals for pain and function; to discuss benefits and risks of opioids, and to
discuss the availability of non-opioid therapies with patients (Dowell, Haegerich, &
Chou, 2016). The CDC Guidelines for the Management of Chronic Pain addresses
patient-centered clinical practices, which include conducting thorough assessments,
considering all possible treatments, and evaluating outcomes (Centers for Disease
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Control and Prevention, 2016). The CDC specifically recommends use of the PEG in
chronic pain management, particularly when considering opioid treatment, as well as to
track outcomes (Dowell et al., 2016).
Locally, in 2018, the Rhode Island Department of Health released pain
management regulations that included guidelines for pain assessment and regulations on
the prescribing of controlled substances. The regulations include required documentation
of a treatment plan for patients with chronic pain who are prescribed opioids for pain
management. At minimum, this documentation is to include a baseline pain assessment,
the objectives used to determine treatment success, an assessment of change in pain and
any change in physical and psychosocial function (McDonald, 2013; Rhode Island
Department of Health, 2018).
The organizational site for this project, known as the CPC, a primary care practice that
has a high prevalence of chronic pain patients, currently utilizes the NRS on all patient visits. The
CPC has many patients who receive opioid and non-opioid pain management services for chronic
pain. The current practice of the CPC is for the medical assistant to ask the patient their NRS
during a rooming process along with vital signs. The results are recorded in the Electronic Health
Record (EHR), however a baseline review of the EHR revealed that the pain score was not
consistently addressed in the documentation by the provider. This was most likely a result of

ineffective use of health information technology as certain screening information
obtained by the medical assistant, including the pain scale, was not automatically
populated into the providers’ clinical documentation.
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Purpose Statement and Specific Aims
This project attempts to determine the feasibility and efficacy of using a
multidimensional pain assessment tool to evaluate chronic pain in a primary care setting.
The specific aim of this project was to evaluate how well the PEG multidimensional pain
assessment tool, which includes functional status and quality of life measures compares
to the unidimensional, NRS which measures pain intensity alone. The efficacy of using
the PEG in a primary care setting to assess chronic pain was evaluated. Also, the project
sought to evaluate how the use of the PEG, in comparison to the NRS, impacts pain
management decisions.
Conceptual/Theoretical Framework
Dunn’s middle-range theory of Adaptation to Chronic Pain (ACP) was the theoretical
basis for this project (Dunn, 2004, 2005). The ADP was deduced from Roy’s adaptation
model (Roy & Andrews, 1999), a grand nursing theory. Middle range theories are useful
for advanced nursing clinical practice and clinical research as they are explanatory and
chosen for their applicability to the specific patient population or setting. The ACP and
Roy’s adaptation model both promote a comprehensive and individualized approach to
pain assessment and management.
The ACP looks at the contextual variables that impact the patient’s experience of
pain and affect their coping strategies. Dunn found a statistically significant indirect
relationship between pain intensity, functional ability, and depressive symptoms (Dunn,
2004). These are all factors evaluated in this project using the PEG scale. The ACP has
significance in how nurses and providers assess and manage patients having chronic pain.
This model fits well with the DNP project utilizing the PEG to assess not only the
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patient’s pain, but also the impact of pain on enjoyment of life and general activity. A
Logic Model (Appendix E.) was developed to guide this quality improvement project.
Methods
This quality improvement project used a comparative design as well as a retrospective
chart review. Both the NRS and PEG assessment scales were utilized for each participant.
The nurse practitioner (NP) conducting the office visit administered the pain scales
verbally to the patient, recording the results in the Electronic Health Record (EHR). Data
collection consisted of the NRS from the current visit and from the two most recent
previous office visits, as well as the PEG score from the current visit. Review of the EHR
was done to obtain the baseline data of pain management strategies that had been
recommended and/or utilized during the visits in which the NRS alone was used.
Setting
This project was conducted at the Rhode Island Hospital Center for Primary Care (CPC)
located in an urban, inner-city section of Providence, Rhode Island. The CPC is part of an
academic teaching center, affiliated with Brown University Medical School. The CPC
serves more than 12,000 patients per year. The patient population is largely low-income
with more than 80 % of patients being under- or uninsured. The CPC is a Patient
Centered Medical Home, a designation by the Agency for Healthcare Research and
Quality (AHRQ) based upon a comprehensive model of primary health care (Agency for
Healthcare Research and Quality, 2012). During a six-month survey of CPC office visits
in 2019, approximately 25% of the patients had a diagnosis of chronic pain.
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Participants
The 25 participants, all established patients of the CPC, consisted of 14 males and 11
females. They were recruited using rolling enrollment at the time of their scheduled
appointment with a nurse practitioner (NP). All participants met criteria of having
chronic pain, defined as lasting a minimum of three months. One participant had chronic
pain for one year, the others had chronic pain for greater than three years. The
participants ranged in age from 49 to 80 years old with an average age of 64 (median 62).
Back pain was the most prevalent pain diagnosis (56%), followed by arthritis (20%),
fibromyalgia (8%), peripheral vascular disease (8%), and neuropathy (8%). Forty percent
of the participants had more than one source of pain and were classified under their
primary complaint. Inclusion criteria were ability to provide informed consent and ability
to verbally respond to the three PEG scale questions. Non-English-speaking patients were
excluded as the PEG has not yet been validated in other languages.
Intervention
During a routine scheduled nurse practitioner (NP) visit, the medical assistant obtained
the NRS according to the CPC routine practice. The NP then obtained written informed
consent from the patient, verified the NRS score, followed by an assessment using the
PEG scale. A“Smart Phrase,” was created so that the provider was able to incorporate the
documentation of the PEG score directly into the clinical office visit note. The remainder of the

office visit continued as usual with documentation in the Electronic Health Record
(EHR).
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Measures
Data collection consisted of the NRS from the current visit and from the two most recent
previous office visits, as well as the PEG score from the current visit. Review of the EHR
was done to obtain baseline data of pain management strategies that had been utilized
during the prior two visits during which the NRS alone was used. The pain management
included strategies, such as medications, physical therapy, cortisone injections,
chiropractic treatment, behavioral health modalities and visits with specialists, such as
orthopedic or spine specialists. Health care services for pain were classified using pain
treatment indicators according to the National Pain Strategy using the categories of
medications, professional services, procedures and miscellaneous non-pharmacologic
measures (Interagency Pain Research Coordinating Committee, 2016) (See Appendix C).

Analysis
Comparative analysis using a t-test was conducted to determine if there was a significant
difference between the NRS and the PEG scale scores. The t-test was used to compare the
values of the mean PEG score to the NRS for each participant, as well as a separate
comparison between the NRS and the P (Pain), the E (Enjoyment) and the G (General
Activity) score. . . A comparison was made of the pain management modalities at
baseline with use of the NRS with the pain management modalities ordered or
recommended based upon the PEG assessment.
Ethical Considerations
Institutional Review Board approval was obtained from both Lifespan (Rhode Island
Hospital) and from Rhode Island College. Informed written consent was obtained from
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all participants (Appendix F.). Privacy was provided during all interactions with the
participants, which took place in an exam room. . . Participation was voluntary, no
treatment was withheld and there were no risks associated with the intervention.
Measures were taken to declassify data, to report it only in aggregate form, and to protect
electronic data from possible breach. The primary researcher and primary investigator
have no disclosures and no costs were incurred.
Results
The PEG score is obtained by adding the score for the P (Pain), E (Enjoyment of life),
and G (General activity), then dividing the total by three. The PEG score was plotted
against the contemporaneous NRS score for each patient (Figure 2).. . There was a
visible, but not significant, increase in PEG scores with higher NRS scores with a
correlation coefficient of 0.22892610, t = 1.12784221. Next, each separate component of
the PEG score (the P, the E, and the G score) was plotted against the contemporaneous
NRS for each patient. The P element of the PEG score was plotted as a function of the
NRS score with a correlation coefficient of 0.15005223 and t = 0.72786607 which is not
significant. Likewise, there was no significant correlation between the E or G of the PEG
score when plotted against the NRS.
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Figure 2. PEG versus Contemporaneous NRS
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Using the coded pain management identifiers from Appendix A, each patient’s
current use of pain management strategies at baseline and those recommended after the
PEG assessment were graphed (Figure 3). The participants used an average of 2.6
different types of medications for pain at baseline, which included adjuvant medications
such as anti-depressants or anti-convulsant medications prescribed specifically for pain.
At baseline, 72% of the participants were prescribed opioid pain medications. Nonpharmacologic pain management was utilized to a lesser degree than pharmacologic
management at baseline. During the past year, 20% had received physical therapy, 32%
had seen a specialist (orthopedic, neurosurgical, or pain management provider), and 24%
had received either a cortisone or epidural injection for pain.
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Figure 3 Coded Pain Management Strategies
Frequencies of Management Strategies Using NRS and PEG Among 25
Patients

Number of Patients

30
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25
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20
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5
0
I.a I.b I.c I.d I.e I.f II.a II.b II.c II.d II.e II.f II.g III.aIII.bIV.aIV.b
Coded Management Strategies

After the PEG assessment, 88% of the participants received new pain
management recommendations. On average, participants received 1.7 new pain
management recommendations during the visit using the PEG assessment. The addition
or renewal of non-pharmacologic pain management were recommended to 23 of 25 of the
participants based upon the PEG assessment. The most common non-pharmacologic
modality recommended was physical therapy (52%) and behavioral health (32%). Sixteen
percent received new referrals to an orthopedic or pain specialist specifically for a
cortisone injection or nerve block.
There were no new opioid prescriptions based upon the assessment with the PEG
scale. The only new pharmacologic recommendations were for topical analgesics (12%),
acetaminophen (8%), and the anticonvulsant gabapentin (4%). Although not typically
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considered to be a pain management modality, assistive devices such as canes, walkers,
braces; and the use of home care services were included in the data collection. Twenty
percent of the participants used an assistive device at baseline and an additional 16%
were recommended to use an assistive device, brace or splint based upon the PEG
assessment. Sixteen percent of participants were recommended to receive home care
services, specifically to assist with limitations in “G” General Activity based upon the
PEG assessment.
Discussion
The purpose of this quality improvement project was to evaluate the use of the PEG, a 3item multidimensional pain assessment tool, compared to the NRS unidimensional tool.
The findings highlight the usefulness of the PEG assessment in providing broader, more
meaningful information compared to the NRS, which measures pain intensity alone.
Although one might expect the pain component of the PEG to track closely to the NRS,
there was not a significant relationship between them. This finding may be explained by
the fact that the PEG assessment asks about “pain on average in the past seven days”,
while the NRS asks about “pain right now.” An example of that was one participant, an
outlier on the graph, whose PEG score was eight but whose NRS score was zero. This
participant explained that her “pain right now” was zero because she had received a
cortisone joint injection on the day prior, however during the past seven days the pain
score had been eight. Another participant who had a low NRS score but higher “P” score
on the PEG explained that the “pain right now” was low because she was sitting but that
the “pain on average in the past seven days” was higher because the pain increases with
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activity. These responses validate the importance and usefulness of a more
comprehensive evaluation when assessing chronic pain.
The most compelling finding was that there was a great deal of variability in the
PEG scores that is not “explained by” the NRS score. This reflects the fact that PEG
scores are affected by factors that are not accounted for in the NRS scores. While the
NRS only assesses pain intensity, the PEG assessment provides a comprehensive
assessment of pain and the impact of pain on enjoyment of life and general activity. The
results show variability between participants, which attests to the highly individualized
nature of chronic pain and how it impacts lives.
The information provided by the PEG assessment led to an increase in
multimodal pain management recommendations, which is consistent with the goals of
chronic pain management (Simon, 2012). The PEG specifically asks about the impact of
pain on functional status and quality of life. This assessment provides information that
can facilitate more individualized and targeted management for the patient with chronic
pain. By including assessments of the impact of pain on enjoyment of life and general
activity, the provider was able to make recommendations, such as for physical therapy
and behavioral health therapy, that may not have been identified by the NRS alone.
Another added benefit from this project was that by using a “Smart Phrase,” the provider
was able to incorporate the documentation of the PEG score directly into the clinical
office visit note. This measure led to efficiency, as well as increased the visibility of the
pain assessment, which in turn increased the likelihood that it would impact patient
management.
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Although the present results clearly support the benefits of using the PEG
compared to the NRS, it is appropriate to recognize several potential limitations, which
include the small sample size. Another limitation is that the PEG scale was only used
during one office visit. The original plan of the project was to assess the participants for
two to three office visits using the PEG, however that did not occur due to the COVID-19
pandemic, which interrupted the project. A longer study would be beneficial in
determining if the PEG scores decrease over time because of more targeted pain
management strategies. Another limitation was that only one provider, the principal
researcher, utilized the PEG scale and conducted the office visit, which could introduce
the possibility of performance bias.
The participants were all English speaking, having chronic pain for over one year,
and the majority were on opioid pain medications. These factors limit the generalizability
of the research findings. A replicated study with a broader patient population would be
useful in providing more generalizable information about this topic.
Sustainability and Scalability
Sustainability for this project and the continued use of the PEG scale in assessing chronic
pain has been strengthened by support at the provider level and organizational level, as
well as by state and federal standards. Infrastructure measures to increase sustainability
were undertaken, including the development of a “Smart Phrase,” which easily places the
PEG assessment tool into the EHR along with documentation of the PEG score. Future
plans that would further increase sustainability include the development of a template for
chronic pain documentation that would include the PEG scale, identifying treatment
objectives, and more details about pain management, such as specific monitoring for
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patients on opioids. Generalizability would be achieved be reproducing this quality
improvement project in a larger patient population with multiple providers and to include
non-English-speaking participants. The use of the PEG scale could easily be scaled to
other demographic settings and a broader population of chronic pain patients.
Although these results support the applicability of the PEG scale, the most
important contribution of these findings may be that they raise a variety of intriguing
questions for future study. In particular, it would be interesting to research the use of the
PEG scale at earlier phases of chronic pain, for example of three to six month duration,
compared to those of well-established chronic pain, to determine if it may have a greater
impact on pain management and patient outcomes. While notable that 72% of this study
population were already on chronic opioid pain medications, it would be of interest to
research the use of the PEG scale in a chronic pain population who were not on opioids to
determine how the information gathered from the PEG may influence pain management
decisions.
Another area for further research would be the influence of the use of the PEG on
patients’ acceptance of treatment recommendations. It was noted that in this project, of
the 12 participants who were advised to have physical therapy as part of their pain
management, nine declined. Further study over a longer period may have different
outcomes, as the provider could compare the PEG score over time and possibly use
motivational interviewing techniques to encourage non-pharmacologic self-management
of pain. This concurs with the 2019 TJC Standards which call for providers to involve the
patient in the “pain management treatment planning process…developing realistic
expectations and measurable goals that are understood by the patient for the degree,
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duration, and reduction of pain …providing education on pain management, treatment
options…” (Joint Commission, 2018).
Conclusion
Much work remains to be done to have a more complete understanding of the extent to
which the use of multidimensional pain assessment instruments may impact and improve
chronic pain management. It is evident that pain intensity ratings alone are inadequate,
and that evaluation of functional outcomes and quality of life measures provide a richer
assessment with the potential for improving pain management. Safe and effective pain
management, which includes both pharmacologic and non-pharmacologic modalities, are
best guided by a multidimensional pain scale, such as the PEG.
Appropriate assessment of chronic pain is the first step towards reducing the
impact of pain, which would have the potential for the improvement the lives of
individuals and families, as well as benefits to society.
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Appendices
Appendix A.

Health care services for pain classified using pain treatment indicators

(National Pain Strategy, 2018)

Type of Service

Professional Services

Oral medications

Procedures

Miscellaneous

Code

Sub-types

I.a.

Primary care visits

I.b.

Pain specialist visits (orthopedic,
rheumatology, neurosurgery, rehabilitation
medicine)

I.c.

Physical therapy visits

I.d.

Psychology/behavioral health visits

I.e.

Chiropractic visits

I.f.

Alternative/complementary care visits

II.a.

Opiods

II.b.

NSAIDs

II.c.

Sedatives, anxiolytics, sleep medications,
muscle relaxants

II.d.

Anticonvulsants

II.e.

Antidepressants

II.f.

Acetaminophen

II.g.

Topical analgesic

III.a.

Surgery

III.b.

Injections, blocks, infusions

IV.a.

Assistive device, brace, walker, cane, splint

IV.b. Home health services
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Appendix B. Timeline

May 2019

DNP Project Proposal—Poster Presentation

Summer 2019

Development of Project Methodology

February 10, 2020

Lifespan (RI Hospital) IRB application approved

February 29, 2020

RI College IRB application approved

February 28 –
March 30, 2020

Enrollment, project implementation and data collection

April 1 –
April 28, 2020

Data Analysis

May 12, 2020

Rhode Island College Doctor of Nursing Practice Symposium
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Appendix C. Force Field Analysis
Forces FOR Change

Score

Change Proposal

Forces AGAINST Change

Score

Change for the better: quality
improvement

5

Changing the status quo

3

Meaningful use (Improving
quality, safety, efficiency, and
reducing health disparities)

5

Time factor (3 item vs 1 item
scale)

3

Increased focus on outcomes

5

Change in process (technical)

3

Patient-centered care

5

Change in practice (MA,
providers)

3

Patient satisfaction

4

Demographic factors
(language, health literacy)

3

5

Pain as the 5th vital sign
routine, 2001 Joint
Commission
recommendation

2

Organizational support
(leadership & providers)

4

Delegation, roles,
accountability (MA not
accountable to NP proposing
change)

2

TOTAL

39

TOTAL

19

2019 Joint Commission revised
pain assessment
recommendations

Implement use of PEG Pain Assessment tool
(PEG) in place of Numeric Pain Rating Scale
(NPRS) in Primary Care setting for
assessment of chronic pain in outpatient
medical practice.
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Appendix D. Sustainability Assessment
Benefits beyond helping patients: Score B
•

quality of care, possible societal benefits

•

improve efficiency, meaningful use, use of a “Smart Phrase”

Credibility of the benefits: Score A
•

benefits to patients and staff are visible and believable

•

benefits are supported by evidence and believed by stakeholders

Adaptability of improved process: Score A
•

the improved process can adapt to, link with, and support other organizational
changes

•

usability in both paper and electronic form

•

no disruption if specific individuals left the project

Effectiveness of the system to monitor progress: Score C
•

need to set up measurement system to monitor progress

•

need feedback system to reinforce benefits

•

need on-going system to provide evidence of impact

•

system is in place to communicate the results

Staff behaviors toward sustaining the change: Score A
•

support and involvement from staff, providers, organizational leadership

•

supported by guidelines and standards (TJC, CDC)

•

staff can share their ideas and believe the change is for the better
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•

staff have been trained but not yet empowered to run PDSA tests

Infrastructure: Score B
•

adequate facilities and equipment (Health Information Technology)

•

plan for sustainability: “Smart Phrase”, communication plan in place

Senior leadership engagement and support: Score B
•

organizational leaders are not highly involved but are moderately visible in their
support of the change process

•

fits with organization’s strategic aims and culture
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Appendix E. Logic Model

High prevalence of
chronic pain.Chronic pain
is associated with many
co-morbidities and
functional impact
The Joint Commission
requires the assessment of
pain and the right to
appropriate pain
management
Numeric Rating Scale
(NRS) unidimensional
pain assessment tool
currently used provides
limited information

Outcomes -- Impact

Outputs

Inputs
Activities
PEG Pain Assessment
Tool

Participation
Educate NP providers
about PEG scale

Data Collection of pain
scale scores

Collect Data and
Disseminate Findings to

Data Collection of pain
management strategies

Other providers and team
members

Data Collection of
Chronic pain Diagnoses

Share information with
leadership

Short
CPC Providers will
demonstrate knowledge
and awareness of Pain
Assessment requirements
and recommendations

Medium
CPC Providers will utilize
the PEG Pain Assessment
tool
CPC Providers will use
the PEG Pain Assessment
tool results to develop
patient-centered pain
management strategies

Long
All CPC providers will
use the PEG Pain
Assessment tool for all
patients having chronic
pain.
Providers will re-assess
improvement in pain
management using the
PEG scale

Patient Satisfaction
Survey

Patient satisfaction
scores will improve

Comparison of NRS to
PEG Scale

Pain management will be
more multi-modal and
less medication-focused.

216-RICR-20-20-4.4 Pain
Management and Prescribing
“The practitioner shall obtain,
evaluate and document the
patient’s health history and
physical examination in the
health record prior to treating for
chronic pain. Documentation of
Treatment…for chronic pain
shall state the objectives…used
to determine treatment
success…”

Assumptions
NRS provides limited information about chronic pain. Pain assessment is required
but providers are not consistent in addressing chronic pain or managing effectively.
TJC standards for pain assessment have been blamed for triggering overprescribing of opioids for pain management
Patient satisfaction scores are important to leadership and administration

External Factors
The Joint Commission requirements for pain screening and assessment
Lifespan mission: “Delivering health with care Culture of safety
RI Department of Health Regulations regarding pain management and prescribing
Diversity of patient population, diversity of provide
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Appendix F. Informed Consent Form
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